Skip to content

LA ROUE PHARMA

Active
Private limited company (pre-2019)founded 2010active for 16 yearsBergense Steenweg 1153, 1070 Anderlecht, BelgiumKBO/BCE: BE 0825.729.029
Summary

LA ROUE PHARMA has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €89,691 and a net result of €49,412. Equity is growing by about 51% per year across the filed financial years. Its solvency ranks better than 47% of 26,023 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 1.5% (low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€312,499total assets 2024
Staff
2 FTE
Equity
€89,691
Profit
€49,412
Financial health
65 Healthy Checked score 2024
Bankruptcy probabilitywithin 12 months
1.5%
Structure
Accounts 71 days overdue0 of 1 deed read
Why 65raises riskFigures for financial year 2024 (filed 23-10-2025)1 financial year not filed after the legal deadline; latest accounts 82 days late; 3 of the last 3 latelowers riskFounded in 2010Liquidity: current ratio 1.64, cash €55,153Show the evidence

Checked score

Score 2024
65 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 66% of its sector peers (NACE 47, micro)
Financial strength · tick = 2023
Strong
Solvency 54+16
equity 28.7% of total assets
Liquidity 44+12
short-term debt 55.0% · cash 17.6%
Profitability 89+6
return on assets 15.8%
Bankruptcy probability, 12 months
1.5% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,188 companies, NACE 47, micro)
Last 24 months 11-2024: 1.7% 12-2024: 1.7%● unchanged vs 11-2024 01-2025: 1.6%▼ -0.1 percentage points vs 12-2024 02-2025: 1.6%● unchanged vs 01-2025 03-2025: 1.6%● unchanged vs 02-2025 04-2025: 1.6%● unchanged vs 03-2025 05-2025: 1.5%▼ -0.1 percentage points vs 04-2025 06-2025: 1.5%● unchanged vs 05-2025 07-2025: 1.6%▲ +0.1 percentage points vs 06-2025 08-2025: 1.9%▲ +0.3 percentage points vs 07-2025 09-2025: 2.2%▲ +0.3 percentage points vs 08-2025 10-2025: 2.8%▲ +0.6 percentage points vs 09-2025highest value 11-2025: 0.8%▼ -2.0 percentage points vs 10-2025 12-2025: 0.8%● unchanged vs 11-2025 01-2026: 0.7%▼ -0.1 percentage points vs 12-2025 02-2026: 0.7%● unchanged vs 01-2026 03-2026: 0.7%● unchanged vs 02-2026 04-2026: 0.7%● unchanged vs 03-2026 05-2026: 0.7%● unchanged vs 04-2026 06-2026: 0.7%● unchanged vs 05-2026 07-2026: 0.6%▼ -0.1 percentage points vs 06-2026lowest value 08-2026: 1.0%▲ +0.4 percentage points vs 07-2026 09-2026: 1.2%▲ +0.2 percentage points vs 08-2026 10-2026: 1.5%▲ +0.3 percentage points vs 09-2026
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.64, compared with 1.61 in 2023; short-term debt: 55% and cash: 17.6% of total assets), but 71.3% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 44% on solvency, 42% on liquidity, 83% on profitability and 94% on growth.

The bankruptcy probability was computed on 09-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
raises risk · Figures for financial year 2024 (filed 23-10-2025)
NBB · annual accounts
lowers risk · Founded in 2010
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
raises risk · 1 financial year not filed after the legal deadline; latest accounts 82 days late; 3 of the last 3 late
NBB · filings
lowers risk · Liquidity: current ratio 1.64, cash €55,153
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 21-10-2025, 82 days later. For context: 47% of Belgian companies file late, and of those that file 1 to 90 days late, 2.0% are now in a legal situation other than normal in the KBO (such as bankruptcy, liquidation or dissolution), against 1.66% of all filers. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
82 days late
2023
62 days late
2022
67 days late
2021
97 days late
2020
101 days late
2019
122 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 89 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · micro…
  2. Annual accounts filedfinancial year 2023 · micro…
  3. Annual accounts filedfinancial year 2022 · full…

Key points

  • Caution: Accounts not fileddeadline was 31-07-2026 71 days late View
  • Positive: Among the best 11% on net resultsector median €4,449 · 25,993 companies €49,412 View
  • Positive: 7 profitable years in a rowprofit 2024: €49,412 7 years View

By topic

Financials

Financial year
2024
Total assets
€312,499
Profit
€49,412
Solvency
28.7%
Total assets▲ 2.8%
Net result
20182024
Go to Financials

Timeline

Events
17
Since
2011
  1. 05-11-2022Annual accounts filed
  2. 31-12-2021Highest result from 2018 to 2024
  3. 09-11-2021Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
07-05-2010
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.